Single-dose fasting bioequivalence study of verapamil hydrochloride extended-release capsules (300 mg; Mylan) to Verelan [verapamil] PM extended-release capsules (300 mg; Schwarz) in healthy volunteers dosed in the evening
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Verapamil (Primary)
- Indications Angina pectoris; Arrhythmias; Hypertension
- Focus Pharmacokinetics
Most Recent Events
- 21 Apr 2008 New trial record.
- 01 Apr 2008 Biomarkers information updated